PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Scott Weiner appointed to Strategic Advisory Board of Florida Institute for the Commercialization of Public Research
News | 05. 14. 2009
The Florida Institute for the Commercialization of Public Research (The Institute) today announced the formation of its Strategic Advisory Board; 15 distinguished industry experts who will provide counsel on technical challenges associated with raising early stage capital and technology commercialization.
